Edgewell Personal Care (EPC) FY2014 results: revenue $2.6 billion, up 6.7% on the year
Edgewell Personal Care Co. (EPC) reported revenue of $2.6 billion for fiscal 2014, the year ended 30 September 2014, up 6.7% on the year before. Net income was $356 million, down 12.5%, and diluted earnings per share $5.69. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2014.
Revenue
$2.6 billion
+6.7% on the year
FY2008FY2014
Operating margin
n/a
FY2008FY2014
Net income
$356 million
-12.5% on the year
FY2008FY2014
Diluted EPS
$5.69
-12.1% on the year
FY2008FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
2,612
2,449
4,567
+6.7%
Cost of revenue
1,322
1,250
2,429
+5.8%
Gross profit
1,290
1,199
2,138
+7.5%
Gross margin
49.4%
49.0%
46.8%
Research and development
69.5
69.3
112
+0.3%
Interest expense
119
127
127
-6.0%
Pre-tax income
146
205
565
-29.0%
Income tax
28.1
50.2
156
-44.0%
Effective tax rate
19.3%
24.4%
27.7%
Net income
356
407
409
-12.5%
Net margin
13.6%
16.6%
9.0%
Diluted EPS
$5.69
$6.47
$6.22
-12.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
572
750
632
-23.7%
Capital expenditure
85.3
90.6
111
-5.8%
Free cash flow
487
659
521
-26.2%
Free cash flow margin
18.6%
26.9%
11.4%
Cash from investing
-263
-89.1
-94.9
Cash from financing
-148
-378
-283
Depreciation and amortisation
136
144
162
-5.7%
Share-based compensation
30.2
33.0
44.9
-8.5%
Buybacks
94.4
0.0
418
Dividends paid
124
106
24.9
+17.3%
Dividend per share
$2.00
$1.70
n/a
+17.6%
Diluted shares, weighted
63m
63m
66m
-0.5%
Shares outstanding at period end
62m
n/a
n/a
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
2,522
2,454
2,070
+2.8%
Debt
2,288
2,238
2,532
+2.3%
Other liabilities
2,118
2,026
2,129
+4.5%
Total liabilities and equity
6,929
6,717
6,731
+3.1%
Fixed assets
752
756
848
-0.5%
Goodwill
1,487
1,476
1,470
+0.8%
Intangible assets
1,847
1,836
1,854
+0.6%
Cash and equivalents
1,129
998
718
+13.1%
Receivables
495
481
677
+3.0%
Inventory
617
616
672
+0.1%
Other assets
601
555
492
+8.3%
Total assets
6,929
6,717
6,731
+3.1%
10-K for the year ended 30 September 2014, filed 18 November 2014: the filing.